EN
HI
Summary
As of 8 Sep, 2026, RPG Life Sciences stock price is ₹2673.4. During the trading session, the stock has moved between an intraday low of ₹2651.00 and an intraday high of ₹2781.10. Over the last 52 weeks, RPG Life Sciences has traded between ₹1733.00 and ₹3082.00.
The stock has recorded a trading volume of 13,615 shares, with a market capitalization of ₹16539015. Its Average Traded Price (ATP) is ₹2711.16, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 6 @ ₹2673.40.
RPG Life Sciences has an upper circuit limit of ₹3265.90 and a lower circuit limit of ₹2177.30. The total value traded stands at ₹3.69 CR, and the delivery percentage for the day is 46.23%.
The stock is currently traded with a market lot size of 1. RPG Life Sciences also offers a dividend yield of 0.88%.
RPG Life Sciences share price chart
RPG Life Sciences Share Key Metrics
Volume
13615.00
Market Cap
4421.54 CR
LTQ@LTP
6@2673.40
ATP
2711.16
Var Margin
19.99 %
Circuit Range
2177.3-3265.9
Delivery %
46.23 %
Value
3.69 CR
ASM/GSM
No
Market Lot
1
RPG Life Sciences Fundamentals
P/E Ratio
38.98
P/B Ratio
7.06
Div. Yield
0.88
Sector P/E
41.43
Sector P/B
3.55
Sec. Div. Yield
0.5
RPG Life Sciences Resistance and Support
Pivot 2699.83
Resistance
First Resistance
2760.76
Second Resistance
2799.93
Third Resistance
2860.86
Support
First Support
2660.66
Second Support
2599.73
Third Support
2560.56
RPG Life Sciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Sep 07 2026 | 2746 | 2673.4 | -1.77% | 2781.1 | 2651 |
| Fri Sep 04 2026 | 2652.39 | 2721.6 | 2.61% | 2739 | 2638.89 |
| Thu Sep 03 2026 | 2596.89 | 2652.39 | 3.41% | 2698.89 | 2583.1 |
RPG Life Sciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-28 | Quarterly Results |
| 2026-04-29 | Audited Results & Final Dividend |
| 2026-01-27 | Quarterly Results |
| 2025-10-17 | Quarterly Results |
| 2025-07-25 | Quarterly Results |
| 2025-04-28 | Audited Results & Final Dividend |
| 2025-01-24 | Quarterly Results |
| 2024-11-07 | Quarterly Results |
RPG Life Sciences News
RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
RPG Life Sciences' subsidiary, RPG Active Pharma, acquired the API business of Raghava Life Sciences for up to Rs. 135 crore. This strategic move adds 300 KL installed capacity and a portfolio of 22 commercialized APIs, strengthening RPGAP's integrated API play.
Sep 02 2026 22:23:17
RPG Life Sciences Ltd - 532983 - Intimation Of Execution Of BTA By RPG Active Pharma Limited (WOS) With Raghava Life Sciences Private Limited
RPG Life Sciences' wholly-owned subsidiary, RPG Active Pharma Limited, will acquire the Active Pharmaceutical Ingredients (APIs) and intermediates business of Raghava Life Sciences Private Limited. This slump sale acquisition is valued up to Rs.135 crores and aligns with RPG Life Sciences' strategy to expand its API business, adding 29 API molecules and business with FY26 revenue of Rs.19 cr.
Sep 02 2026 22:18:09
Read More
RPG Life Sciences Management
| Name | Position |
|---|---|
| Harsh Goenka | Chairman |
| Ashok Nair | Managing Director |
RPG Life Sciences Similar Stocks
IOL Chemicals And Pharmaceuticals Ltd.
213.04
13.09 (6.55%)
Orchid Pharma Ltd.
947.10
-7.55 (0.79%)
FDC Ltd.
342.15
-0.65 (0.19%)
Artemis Medicare Services Ltd.
343.50
10.70 (3.22%)
Supriya Lifescience Ltd.
909.10
56.25 (6.60%)
Gufic Biosciences Ltd.
448.00
3.10 (0.70%)
Aarti Drugs Ltd.
423.00
-8.65 (2.00%)
Unichem Laboratories Ltd.
569.75
19.55 (3.55%)
Indraprastha Medical Corporation Ltd.
351.40
1.70 (0.49%)
SMS Pharmaceuticals Ltd.
397.95
5.45 (1.39%)
RPG Life Sciences FAQs
The Buying Price of RPG Life Sciences share is 2673.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy RPG Life Sciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for RPG Life Sciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of RPG Life Sciences shares is 38.98. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio RPG Life Sciences shares is 7.06. Useful to assess the stock's value relative to its book value.
To assess RPG Life Sciences’s valuation compare Sector P/E, P/B which are 41.43 & 3.55 with sector averages, along with growth rates and financial metrics.
The Market Cap of RPG Life Sciences is 4421.54 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of RPG Life Sciences share price is 3082.00 & 1733.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
RPG Life Sciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
